Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A phase II, multicenter, randomized, open-label study to evaluate the safety and efficacy of 400 mg of ribociclib in combination with non-steroidal aromatase inhibitors for the treatment of pre- and postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer who received no prior therapy for advanced disease (CLEE011A2207)

  • Details

ClinicalTrials.gov ID: NCT03822468
Diagnosis Type: NA
USOR Number: 19004

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

CLEE011O12301C (TRIO033): A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE).

  • Details

ClinicalTrials.gov ID: NCT03701334
Diagnosis Type: NA
USOR Number: 19058

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PCR2002 Quest) (64091742PCR2002)

  • Details

ClinicalTrials.gov ID: NCT03431350
Diagnosis Type: NA
USOR Number: 19146

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer (NuTide:121)

  • Details

ClinicalTrials.gov ID: NCT04163900
Diagnosis Type: NA
USOR Number: 19120

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: Non-Hodgkins
USOR Number: 18155

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: CLL
USOR Number: 18155

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

CYCLONE 2: A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

(Amgen 20180015) A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination with Lenalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2).

  • Details

ClinicalTrials.gov ID: NCT03859427
Diagnosis Type: NA
USOR Number: 19036

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/PD-L1 Based Immunotherapy (IMMU-132-06)

  • Details

ClinicalTrials.gov ID: NCT03547973
Diagnosis Type: ALL
USOR Number: 18283

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant (54767414MMY3021)

  • Details

ClinicalTrials.gov ID: NCT03901963
Diagnosis Type: NA
USOR Number: 19247

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

ULTRA-V: Phase 2 Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax (U2-V) in Subjects with Chronic Lymphocytic Leukemia (CLL)(U2-VEN-207)

  • Details

ClinicalTrials.gov ID: NCT03801525
Diagnosis Type: CLL
USOR Number: 19205

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

D9311C00001; GOG-3041; ENGOT-EN10: A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  • Details

ClinicalTrials.gov ID: NCT04269200
Diagnosis Type: NA
USOR Number: 19221

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in subjects with Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) who have failed at least two prior chemotherapy regimens (IMMU-132-09)

  • Details

ClinicalTrials.gov ID: NCT03901339
Diagnosis Type: NA
USOR Number: 18282

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: AML
USOR Number: 18168

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number: 18103

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: NSCLC
USOR Number: 19192

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Non-Hodgkins
USOR Number: 11282

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: NA
USOR Number: 19208

  • Practice Details

4715 Arapahoe Avenue
Boulder, Colorado 80303
552.13 mi. away
P: (303) 385-2000

More Details View Practice Page

Pages